Search Results - "Baghai, T."

Refine Results
  1. 1

    SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression by ZILL, P, BAGHAI, T. C, ZWANZGER, P, SCHÜLE, C, ESER, D, RUPPRECHT, R, MÖLLER, H.-J, BONDY, B, ACKENHEIL, M

    Published in Molecular psychiatry (01-11-2004)
    “…Tryptophan hydroxylase (TPH), being the rate-limiting enzyme in the biosynthesis of serotonin plays a major role as candidate gene in several psychiatric…”
    Get full text
    Journal Article
  2. 2

    Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile by Nothdurfter, C., Rammes, G., Baghai, T. C., Schüle, C., Schumacher, M., Papadopoulos, V., Rupprecht, R.

    Published in Journal of neuroendocrinology (01-01-2012)
    “…Anxiety disorders are frequent and highly disabling diseases with considerable socio‐economic impact. In the treatment of anxiety disorders, benzodiazepines…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? by Schüle, C, Eser, D, Baghai, T.C, Nothdurfter, C, Kessler, J.S, Rupprecht, R

    Published in Neuroscience (15-09-2011)
    “…Abstract In the past decades considerable evidence has emerged that so-called neuroactive steroids do not only act as transcriptional factors in the regulation…”
    Get full text
    Journal Article
  4. 4

    Gut microbiota and depression : Pathophysiology of depression: hypothalamic-pituitary-adrenal axis and microbiota-gut-brain axis by Lima-Ojeda, J M, Rupprecht, R, Baghai, T C

    Published in Nervenarzt (01-12-2020)
    “…Depression is a chronic disease with a complex multifactorial and still not fully clarified etiology. Due to new insights after recent investigations of the…”
    Get full text
    Journal Article
  5. 5

    Translocator Protein (TSPO) Expression in Platelets of Depressed Patients Decreases during Antidepressant Therapy by Sarubin, N, Baghai, T C, Lima-Ojeda, J M, Melchner, D, Hallof-Buestrich, H, Wolf, L, Hilbert, S, Milenkovic, V M, Wetzel, C H, Rupprecht, R, Nothdurfter, C

    Published in Pharmacopsychiatry (01-09-2016)
    “…A promising candidate in the field of pharmacological treatment options regarding major depressive disorder (MDD) is the mitochondrial translocator protein (18…”
    Get more information
    Journal Article
  6. 6

    Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism by BAGHAI, T. C, BINDER, E. B, DEIML, T, UHR, M, ILLIG, T, WICHMANN, H.-E, MODELL, S, NOTHDURFTER, C, HOLSBOER, F, MÜLLER-MYHSOK, B, MÖLLER, H.-J, RUPPRECHT, R, SCHULE, C, BONDY, B, SALYAKINA, D, ESER, D, LUCAE, S, ZWANZGER, P, HABERGER, C, ZILL, P, ISING, M

    Published in Molecular psychiatry (01-11-2006)
    “…Angiotensin-converting enzyme (ACE) is assumed to influence the activity of the hypothalamic-pituitary-adrenocortical (HPA) system, which shows hyperactivity…”
    Get full text
    Journal Article
  7. 7

    Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression by Frodl, T, Koutsouleris, N, Bottlender, R, Born, C, Jäger, M, Mörgenthaler, M, Scheuerecker, J, Zill, P, Baghai, T, Schüle, C, Rupprecht, R, Bondy, B, Reiser, M, Möller, H-J, Meisenzahl, E M

    Published in Molecular psychiatry (01-12-2008)
    “…The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult…”
    Get full text
    Journal Article
  8. 8

    Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity by SCHÜLE, C, ROMEO, E, UZUNOV, D. P, ESER, D, DI MICHELE, F, BAGHAI, T. C, PASINI, A, SCHWARZ, M, KEMPTER, H, RUPPRECHT, R

    Published in Molecular psychiatry (01-03-2006)
    “…Concentrations of 3α-reduced neuroactive steroids are altered in depression and normalize after antidepressant pharmacotherapy with selective serotonin…”
    Get full text
    Journal Article
  9. 9

    Gut microbiome and major depressive disorder : The other side of ourselves by Manook, A, Hiergeist, A, Rupprecht, R, Baghai, T C

    Published in Nervenarzt (01-11-2016)
    “…Microbiological ecology and its ambition to describe the complete genome of complex living communities as a whole, have given us powerful tools to characterize…”
    Get full text
    Journal Article
  10. 10

    St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy by Laakmann, G, Schüle, C, Baghai, T, Kieser, M

    Published in Pharmacopsychiatry (01-06-1998)
    “…In a randomized, double-blind, placebo-controlled, multicenter study, the clinical efficacy and safety of two different extracts of St. John's wort were…”
    Get more information
    Journal Article
  11. 11

    Neuroactive steroids as modulators of depression and anxiety by Eser, D., Romeo, E., Baghai, T.C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., Rupprecht, R.

    Published in Neuroscience (01-01-2006)
    “…Certain neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially 3α-reduced pregnane steroids are potent positive…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Neuroactive steroids and affective disorders by Eser, D., Schüle, C., Baghai, T.C., Romeo, E., Uzunov, D.P., Rupprecht, R.

    Published in Pharmacology, biochemistry and behavior (01-08-2006)
    “…Neuroactive steroids modulate neurotransmission through modulation of specific neurotransmitter receptors such as γ-aminobutyric acid type A (GABA A)…”
    Get full text
    Journal Article
  13. 13

    Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients by Schüle, Cornelius, Zill, Peter, Baghai, Thomas C., Eser, Daniela, Zwanzger, Peter, Wenig, Nadine, Rupprecht, Rainer, Bondy, Brigitta

    Published in Psychoneuroendocrinology (01-09-2006)
    “…Data suggest that both neurotrophic and hypothalamic–pituitary–adrenocortical (HPA) systems are involved in the pathophysiology of depression. The aim of the…”
    Get full text
    Journal Article
  14. 14

    Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic-Pituitary-Adrenal-Axis Activity: A Placebo-Controlled Study by ZWANZGER, P, ESER, D, AICHER, S, SCHÜLE, C, BAGHAI, T. C, PADBERG, F, ELLA, R, MÖLLER, H-J, RUPPRECHT, R

    Published in Neuropsychopharmacology (01-05-2003)
    “…Cholecystokinin-tetrapeptide (CCK-4) induces panic attacks both in patients with panic disorder (PD) and healthy volunteers. It has been shown that panic…”
    Get full text
    Journal Article
  15. 15

    Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4 by Dieler, A C, Sämann, P G, Leicht, G, Eser, D, Kirsch, V, Baghai, T C, Karch, S, Schüle, C, Pogarell, O, Czisch, M, Rupprecht, R, Mulert, C

    Published in Current pharmaceutical design (01-11-2008)
    “…Pharmacological magnetic resonance imaging (phMRI) is a method to study effects of psychopharmacological agents on neural activation. Changes of the blood…”
    Get more information
    Journal Article
  16. 16

    Combined action of the ACE D- and the G-protein β3 T-allele in major depression : a possible link to cardiovascular disease? by BONDY, B, BAGHAI, T. C, ZILL, P, BOTTLENDER, R, JAEGER, M, MINOV, C, SCHULE, C, ZWANZGER, P, RUPPRECHT, R, ENGEL, R. R

    Published in Molecular psychiatry (01-12-2002)
    “…Although it is well established that depression is a major risk factor for the development of coronary artery disease and that cerebrovascular disease can be a…”
    Get full text
    Journal Article
  17. 17

    Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder by Zwanzger, P, Eser, D, Nothdurfter, C, Baghai, T C, Möller, H-J, Padberg, F, Rupprecht, R

    Published in Pharmacopsychiatry (01-11-2009)
    “…There is evidence that a decreased GABAergic tone plays a role in the pathophysiology of panic disorder (PD). Selective GABAergic treatment has been suggested…”
    Get more information
    Journal Article
  18. 18

    S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations by Pfennig, A, Bschor, T, Baghai, T, Bräunig, P, Brieger, P, Falkai, P, Geissler, D, Gielen, R, Giesler, H, Gruber, O, Kopp, I, Meyer, T D, Möhrmann, K H, Muche-Borowski, C, Padberg, F, Scherk, H, Strech, D, Bauer, M

    Published in Nervenarzt (01-05-2012)
    “…Bipolar disorders are severe psychiatric disorders with extensive individual and health economic consequences. Starting in 2007 the first German evidence and…”
    Get full text
    Journal Article
  19. 19

    The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression by Zwanzger, P., Baghai, T.C., Padberg, F., Ella, R., Minov, C., Mikhaiel, P., Schüle, C., Thoma, H., Rupprecht, R.

    Published in Psychoneuroendocrinology (01-04-2003)
    “…Background: Hypothalamic-pituitary-adrenocortical (HPA) dysregulation assessed by the combined dexamethasone corticotropin releasing hormone test (DEX/CRH…”
    Get full text
    Journal Article
  20. 20